214 related articles for article (PubMed ID: 31775395)
21. The Critical Gene Screening to Prevent Chromophobe Cell Renal Carcinoma Metastasis through TCGA and WGCNA.
Yan C; Yang Y; Tang Y; Zheng X; Xu B
J Oncol; 2022; 2022():2909095. PubMed ID: 36284630
[TBL] [Abstract][Full Text] [Related]
22. cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach.
Ahmed MB; Alghamdi AAA; Islam SU; Lee JS; Lee YS
Cells; 2022 Jun; 11(13):. PubMed ID: 35805104
[TBL] [Abstract][Full Text] [Related]
23. Clinical Implication of Phosphodiesterase-4-Inhibition.
Schick MA; Schlegel N
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163131
[TBL] [Abstract][Full Text] [Related]
24. Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC.
Zhang Y; Wang H; Xiao H
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34065108
[TBL] [Abstract][Full Text] [Related]
25. Phosphodiesterase 4D Depletion/Inhibition Exerts Anti-Oncogenic Properties in Hepatocellular Carcinoma.
Ragusa F; Panera N; Cardarelli S; Scarsella M; Bianchi M; Biagioni S; Giorgi M; Alisi A; Massimi M
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34062786
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of long-term survivors of hepatocellular carcinoma.
Shen J; Hu J; Wu J; Luo X; Li Y; Li J
Aging (Albany NY); 2021 Mar; 13(5):7517-7537. PubMed ID: 33686022
[TBL] [Abstract][Full Text] [Related]
27. Repurposing approved drugs for cancer therapy.
Schein CH
Br Med Bull; 2021 Mar; 137(1):13-27. PubMed ID: 33517358
[TBL] [Abstract][Full Text] [Related]
28. Connexins and cAMP Cross-Talk in Cancer Progression and Metastasis.
Chen CX; Luo KJ; Yang JP; Huang YC; Cardenas ER; Nicholson BJ; Jiang JX
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33379194
[TBL] [Abstract][Full Text] [Related]
29. Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma.
Bian S; Ni W; Zhu M; Song Q; Zhang J; Ni R; Zheng W
Front Mol Biosci; 2020; 7():604766. PubMed ID: 33363211
[No Abstract] [Full Text] [Related]
30. Interrupting Neuron-Tumor Interactions to Overcome Treatment Resistance.
Hunt PJ; Kabotyanski KE; Calin GA; Xie T; Myers JN; Amit M
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322770
[TBL] [Abstract][Full Text] [Related]
31. Complex roles of cAMP-PKA-CREB signaling in cancer.
Zhang H; Kong Q; Wang J; Jiang Y; Hua H
Exp Hematol Oncol; 2020 Nov; 9(1):32. PubMed ID: 33292604
[TBL] [Abstract][Full Text] [Related]
32. Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology.
Bazzichetto C; Luchini C; Conciatori F; Vaccaro V; Di Cello I; Mattiolo P; Falcone I; Ferretti G; Scarpa A; Cognetti F; Milella M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266496
[TBL] [Abstract][Full Text] [Related]
33. Special Issue on "New Advances in Cyclic AMP Signalling"-An Editorial Overview.
Yarwood SJ
Cells; 2020 Oct; 9(10):. PubMed ID: 33053803
[TBL] [Abstract][Full Text] [Related]
34. Evaluating Distribution and Prognostic Value of New Tumor-Infiltrating Lymphocytes in HCC Based on a scRNA-Seq Study With CIBERSORTx.
Li L; Shen L; Ma J; Zhou Q; Li M; Wu H; Wei M; Zhang D; Wang T; Qin S; Xing T
Front Med (Lausanne); 2020; 7():451. PubMed ID: 33043022
[TBL] [Abstract][Full Text] [Related]
35. Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
Giorgi M; Cardarelli S; Ragusa F; Saliola M; Biagioni S; Poiana G; Naro F; Massimi M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32727145
[TBL] [Abstract][Full Text] [Related]
36. Role and Mechanism of Rhizopus Nigrum Polysaccharide EPS1-1 as Pharmaceutical for Therapy of Hepatocellular Carcinoma.
Chu G; Miao Y; Huang K; Song H; Liu L
Front Bioeng Biotechnol; 2020; 8():509. PubMed ID: 32582655
[No Abstract] [Full Text] [Related]
37. Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma.
Massimi M; Ragusa F; Cardarelli S; Giorgi M
Cells; 2019 Nov; 8(12):. PubMed ID: 31775395
[TBL] [Abstract][Full Text] [Related]
38. Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival.
Massimi M; Cardarelli S; Galli F; Giardi MF; Ragusa F; Panera N; Cinque B; Cifone MG; Biagioni S; Giorgi M
J Cell Biochem; 2017 Jun; 118(6):1401-1411. PubMed ID: 27859531
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
[TBL] [Abstract][Full Text] [Related]
40. Inhibitors of Phosphodiesterase 4, but Not Phosphodiesterase 3, Increase β2-Agonist-Induced Expression of Antiinflammatory Mitogen-Activated Protein Kinase Phosphatase 1 in Airway Smooth Muscle Cells.
Patel BS; Prabhala P; Oliver BG; Ammit AJ
Am J Respir Cell Mol Biol; 2015 May; 52(5):634-40. PubMed ID: 25296132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
